Irofulven as first line therapy in recurrent or metastatic...

Cancer Chemotherapy and Pharmacology 2007 / 03 Vol. 59; Iss. 3

Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

W. Yeo, M. Boyer, H. C. Chung, S. Y. K. Ong, R. Lim, Benny Zee, B. Ma, K. C. Lam, F. K. F. Mo, E. K. W. Ng, R. Ho, S. Clarke, J. K. Roh, P. Beale, S. Y. Rha, H. C. Jeung, R. Soo, B. C. Goh, A. T. C. C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
59
Language:
english
Pages:
6
DOI:
10.1007/s00280-006-0270-1
Date:
March, 2007
File:
PDF, 266 KB
english, 2007
Conversion to is in progress
Conversion to is failed